Picture of Sotac Pharmaceuticals logo

SOTAC Sotac Pharmaceuticals Income Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual income statement for Sotac Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUSARS
Standards:
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinal
Revenue
Total Revenue286488732580
Cost of Revenue
Gross Profit71.894.5172179
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses281500681514
Operating Profit4.62-11.450.165.8
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes3.57-20.646.959.6
Provision for Income Taxes
Net Income After Taxes0.875-23.728.845
Net Income Before Extraordinary Items
Net Income0.875-23.728.845
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income0.875-23.728.845
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.052-2.143.625.58